Cargando…

Increasing patient participation in oncology clinical trials

AIM: Timely recruitment of eligible participants is essential for the success of clinical trials, with insufficient accrual being the leading cause for premature termination of both oncology and non‐oncology trials. METHODS: In this paper we further elaborate on the challenges for patient participat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jie, Lu, Ying, Kummar, Shivaani
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	REVIEWS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939168/ https://www.ncbi.nlm.nih.gov/pubmed/36043431 http://dx.doi.org/10.1002/cam4.5150

Ejemplares similares

GeneMed: An Informatics Hub for the Coordination of Next-Generation Sequencing Studies that Support Precision Oncology Clinical Trials
por: Zhao, Yingdong, et al.
Publicado: (2015)

Molecular insights into desmoid tumors
por: Bui, Nam, et al.
Publicado: (2017)

Beyond Participation: Evaluating the Role of Patients in Designing Oncology Clinical Trials
por: Farah, Eliya, et al.
Publicado: (2023)

Reviewing the role of healthy volunteer studies in drug development
por: Karakunnel, Joyson J., et al.
Publicado: (2018)

Clinical Predictors of Early Trial Discontinuation for Patients Participating in Phase I Clinical Trials in Oncology
por: Douma, Joeri A. J., et al.
Publicado: (2021)

COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
por: Desai, Aakash, et al.
Publicado: (2021)

Historical Perspectives on Ethical and Regulatory Aspects of Human Participants Research: Implications for Oncology Clinical Trials in Africa
por: Salhia, Bodour, et al.
Publicado: (2020)

Advances in using PARP inhibitors to treat cancer
por: Kummar, Shivaani, et al.
Publicado: (2012)

Elderly patients’ participation in clinical trials
por: Shenoy, Premnath, et al.
Publicado: (2015)

Further evidence of clinical benefit associated with participation in phase I oncology trials
por: Markman, M
Publicado: (2008)

Author Correction: COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
por: Desai, Aakash, et al.
Publicado: (2021)

Exploration of potential risk factors for COVID-19 severity in patients participating in oncology clinical trials
por: Mohiuddin, Md, et al.
Publicado: (2021)

A Phase I Study of Ganetespib and Ziv‐Aflibercept in Patients with Advanced Carcinomas and Sarcomas
por: Meehan, Robert, et al.
Publicado: (2018)

Patient Participation in Clinical Trials of Oncology Drugs and Biologics Preceding Approval by the US Food and Drug Administration
por: Hutchinson, Nora, et al.
Publicado: (2021)

Racial and Ethnic Inequities in US Oncology Clinical Trial Participation From 2017 to 2022
por: Pittell, Harlan, et al.
Publicado: (2023)

Landscape of Oncology Clinical Trials in Africa
por: Odedina, Folakemi T., et al.
Publicado: (2020)

Post-trial access to treatment for patients participating in clinical trials
por: Doval, Dinesh Chandra, et al.
Publicado: (2015)

Basic Design Considerations for Clinical Trials in Oncology
por: Piantadosi, Steven, et al.
Publicado: (1992)

Guidelines for Analysis and Reporting of Clinical Trials in Oncology
por: Piantadosi, Steven, et al.
Publicado: (1993)

A Case-Control Study Examining Disparities in Clinical Trial Participation Among Breast Surgical Oncology Patients
por: Fayanju, Oluwadamilola M, et al.
Publicado: (2019)

Modeling Pharmacodynamic Response to the Poly(ADP-Ribose) Polymerase Inhibitor ABT-888 in Human Peripheral Blood Mononuclear Cells
por: Ji, Jiuping, et al.
Publicado: (2011)

Barriers and Facilitators to Conducting Oncology Clinical Trials in the UAE
por: Al-Shamsi, Humaid O.
Publicado: (2022)

Radioimmunotherapy in Oncology: Overview of the Last Decade Clinical Trials
por: Rondon, Aurélie, et al.
Publicado: (2021)

Hope and meaning-making in phase 1 oncology trials: a systematic review and thematic synthesis of qualitative evidence on patient-participant experiences
por: Escritt, Kate, et al.
Publicado: (2022)

Increasing the efficiency of trial-patient matching: automated clinical trial eligibility Pre-screening for pediatric oncology patients
por: Ni, Yizhao, et al.
Publicado: (2015)

Intraoperative Hypotension Increased Risk in the Oncological Patient
por: Mohammad Shehata, Islam, et al.
Publicado: (2021)

Analysis of Female Participant Representation in Registered Oncology Clinical Trials in the United States from 2008 to 2020
por: Perera, Nirosha D, et al.
Publicado: (2023)

Credentialing for participation in clinical trials
por: Followill, David S., et al.
Publicado: (2012)

Predicting Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy Using a Deep Convolutional Neural Network–Based Artificial Intelligence Tool
por: Krishnamurthy, Savitri, et al.
Publicado: (2023)

Translating clinical trials from human to veterinary oncology and back
por: Fürdös, Irene, et al.
Publicado: (2015)

The Impact of the COVID-19 Pandemic on Oncology Care and Clinical Trials
por: Ali, Jennyfa K., et al.
Publicado: (2021)

The progress of peptide vaccine clinical trials in gynecologic oncology
por: Tang, Mi, et al.
Publicado: (2022)

Challenges in launching multinational oncology clinical trials in India
por: Saini, Kamal S., et al.
Publicado: (2013)

Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials
por: Marcath, Lauren A., et al.
Publicado: (2018)

CLRM-08 TAILORING CLINICAL TRIALS TO INCREASE PATIENT ENGAGEMENT: IMPACT ON PATIENT-REPORTED OUTCOMES IN ONCOLOGY
por: Khakwani, Saima, et al.
Publicado: (2023)

Clinical outcome assessment trends in clinical trials—Contrasting oncology and non‐oncology trials
por: Kim, Yeonju, et al.
Publicado: (2023)

Physician participation in clinical research and trials: issues and approaches
por: Rahman, Sayeeda, et al.
Publicado: (2011)

Engaging African ancestry participants in SLE clinical trials
por: Anjorin, Aderike, et al.
Publicado: (2018)

Combining Isotopic Tracer Techniques to Increase Efficiency of Clinical Pharmacokinetic Trials in Oncology
por: Roosendaal, Jeroen, et al.
Publicado: (2020)

Benefits of Participation in Clinical Trials: An Umbrella Review
por: Bouzalmate-Hajjaj, Amira, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_52agddtsvkla15dh3c5mdf7hoi